Hypera Rule of 40
The Rule of 40 of Hypera (HYPE3.SA) as of Oct 11, 2026 is 28.70 %. In the previous year, Rule of 40 was 20.24 % — a change of 41.78% (higher).
Get this data via API
Financial Data API
Rule of 40
28.70 %
YoY
41.78%
Last updated:
Rule of 40 of Hypera is 2025 28.70 % . Rule of 40 of Hypera was 2024 20.24 % . It decreases by 41.78% higher compared to the previous year.
The Hypera Rule of 40 history
3 Years
10 Years
25 Years
Max
Rule of 40
Date
Rule of 40
Jan 1, 2018
36.73 BRL
Jan 1, 2019
22.79 BRL
Jan 1, 2020
58.30 BRL
Jan 1, 2021
79.50 BRL
Jan 1, 2022
62.12 BRL
Jan 1, 2023
33.75 BRL
Jan 1, 2024
20.24 BRL
Jan 1, 2025
28.70 BRL
| YEAR | Rule of 40 | YoY |
|---|---|---|
| 28.70 % | +41.78% | |
| 20.24 % | -40.04% | |
| 33.75 % | -45.66% | |
| 62.12 % | -21.87% | |
| 79.50 % | +36.37% | |
| 58.30 % | +155.81% | |
| 22.79 % | -37.95% | |
| 36.73 % | -13.94% | |
| 42.68 % | -2.62% | |
| 43.83 % | -732.05% | |
| -6.93 % | — |
Access this data via the Eulerpool API
Hypera Stock analysis
What does Hypera do? Hypera SA is a Brazilian pharmaceutical company founded in 2001, specializing in the development, production, and distribution of drugs, generics, medical devices, and cosmetic products primarily for the Brazilian healthcare industry. Hypera is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Hypera stock
Rule of 40 of Hypera is 28.70 % in 2025.
On Eulerpool you can find the complete historical development of Rule of 40 Hypera since 2006 – with annual values, charts, and detailed analysis.
The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.
Access this data via the Eulerpool API
Quality — Hypera
All Key Metrics — Hypera
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth